Abstract
A multicenter study was conducted to test the efficacy and safety of fibrin sealant (FS) as a topical hemostatic agent in patients undergoing either reoperative cardiac surgery (redo) or emergency resternotomy. A total of 333 patients from 11 centers in the United States were included in the study. Patients were randomly assigned to initially receive FS or a conventional topical hemostatic agent when such was required during surgery. The end-point used to evaluate the agent’s efficacy was local hemostasis, recording the number of bleeds controlled within 5 min The FS group from the prospective study was compared to historical matched controls for postoperative blood loss, need for resternotomy, blood products received, and hospital stay and to historical nonmatched controls for incidence of resternotomy and mortality. The results showed a 92.6% success rate for FS in controlling bleeding within 5 min of application, compared to only 12.4% success with conventional topical agents (p < 0.001). FS also rapidly controlled 82.0% of those bleeds not initially controlled by conventional agents. High-volume postoperative blood loss was significantly less (p < 0.05) in the FS group vs. matched controls. Additionally, resternotomy rates in redos were significantly lower in the FS group (5.6%) compared to nonmatched historical controls (10%; p = 0.0089). There were no significant differences in hospital stay or blood products received between FS and matched historical controls and no difference in mortality between the FS group and nonmatched historical controls. There were no documented adverse reactions, transmission of viral infection (hepatitis B, non-A/non-B hepatitis), or HIV seroconversion. This study shows that FS is safe and highly effective in controlling localized bleeding in cardiac operations. FS reduces postoperative blood loss and decreases the incidence of emergency resternotomy. These findings make FS a valuable hemostatic agent in cardiac surgery.
Published previously in the Journal of Thoracic and Cardiovascular Surgery, vol. 97, no.2, pp 194–203, Feb. 1989. Reprinted by permission of C.V. Mosby Yearbook, Inc., USA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borst HG, Haverich A (eds) (1982) Fibrin seal in cardiovascular surgery: proceedings of an international workshop, Hannover, 14 Nov 1981. Thorac Cardiovasc Surg 30 (4): 195–224
Borst HG, Haverich A, Walterbusch G, Maatz W (1982) Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovas Surg 84: 548–553
Haverich A, Walterbusch G, Borst HG (1981) The use of fibrin glue for sealing vascular prostheses of high porosity. Thorac Cardiovasc Surg 29: 252–254
Koveker G (1982) Clinical application of fibrin glue in cardiovascular surgery. Thorac Cardiovasc Surg 30: 228–229
Fleiss JL (1973) Statistical methods for rates and proportion. Wiley, New York
Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RI, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J, Smith M, Chute LE (1986) Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 314: 1402–1406
Braunwald NS, Gay W, Tatooles CJ (1966) Evaluation of cross-linked gelatin as a tissue adhesive and hemostatic agent: an experimental study. Surgery 59: 1024–1030
Collins JA, James PM, Levitsky SA, Bredenburg CE, Anderson RW, Leonard F, Hardaway RM (1969) Cyanoacrylate adhesives as topical hemostatic aids, II, Clinical use in seven combat casualties. Surgery 65: 260–263
Spängler HP (1976) Gewebeklebung and lokale Blutstillung mit Fibrinogen, Thrombin and Blutgerinnungsfactor XIII. Wien Klin Wochenschr 88 [Supp] 491: 1–18
Bachet J, Gigou F, Laurian C, Bical O, Goudot B, Guilmet D (1982) Four-year clinical experience with the gelatin-resorcine-formol biological glue in acute aortic dissection. J Thorac Cardiovasc Surg 83: 212–217
Akrami R, Kalmar P, Pokar H, Tilsner V (1978) Abdichtung von Kunststoffprothesen beim Ersatz der Aorta im thorakalen Bereich. Thoraxchirurgie 26: 144–147
Koveker G, DeVivie ER, Hellberg KD (1981) Clinical experience with fibrin glue in cardiac surgery. Thorac Cardiovasc Surg 29: 287–289
Huth C, Seybold-Epting W, Hoffineister H-E (1982) Local hemostasis with fibrin glue (Tissucol) after intracardiac repair of tetralogy of Fallot and transposition of the great arteries (TGA). Thorac Cardiovasc Surg 30 [Suppl 1]: 30
Rousou JA, Engelman RM, Breyer RH (1984) Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg 38: 409–410
Scheele J, Schricker KT, Goy RD, Lampe I, Parris R (1981) Hepatitisrisiko der Fibrinklebung in der Allgemeinchirurgie. Med Welt 32: 783–788
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rousou, J. et al. (1995). Randomized Clinical Trial of Fibrin Sealant in Cardiac Surgery Patients Undergoing Resternotomy or Reoperation: A Multicenter Study. In: Schlag, G., Wolner, E., Eckersberger, F. (eds) Fibrin Sealing in Surgical and Nonsurgical Fields. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79227-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-79227-4_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58381-3
Online ISBN: 978-3-642-79227-4
eBook Packages: Springer Book Archive